{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:14:49Z","timestamp":1791011689340,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.euroneuro.2009.11.002","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T15:09:27Z","timestamp":1261062567000},"page":"112-122","source":"Crossref","is-referenced-by-count":73,"title":["Potential anxiogenic effects of cannabinoid CB1 receptor antagonists\/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142"],"prefix":"10.1016","volume":"20","author":[{"given":"K.S.","family":"Sink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.N.","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.E.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"Markus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.K.","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Makriyannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2009.11.002_bib1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0091270008317591","article-title":"Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers","volume":"48","author":"Addy","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib2","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1023\/A:1020968922151","article-title":"In-vitro and in-vivo action of cannabinoids","volume":"24","author":"Akinshola","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0306-4522(98)00675-7","article-title":"Blockade of cannabinoid receptors by SR141716 selectively increases fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function","volume":"91","author":"Alonso","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0091-3057(01)00578-0","article-title":"Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters","volume":"70","author":"Arevalo","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s002130050326","article-title":"Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors","volume":"132","author":"Arnone","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1037\/0735-7036.100.2.101","article-title":"Defensive behavior of laboratory and wild Rattus norvegicus","volume":"100","author":"Blanchard","year":"1986","journal-title":"J. Comp. Psychol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0306-4522(96)00632-X","article-title":"Elicitation and reduction of fear: behavioural and neuroendocrine indices and brain induction of the immediate-early gene c-fos","volume":"78","author":"Campeau","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib8","doi-asserted-by":"crossref","first-page":"R2185","DOI":"10.1152\/ajpregu.00663.2007","article-title":"A neutral CB1 receptor antagonist reduces weight gain in rat","volume":"293","author":"Chambers","year":"2007","journal-title":"Am. J. Physiol., Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF02245598","article-title":"Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat","volume":"121","author":"Cole","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib10","doi-asserted-by":"crossref","first-page":"PL113","DOI":"10.1016\/S0024-3205(98)00322-1","article-title":"Appetite suppression and weight loss after the cannabinoid antagonist SR 141716","volume":"63","author":"Colombo","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(98)00184-8","article-title":"Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists","volume":"349","author":"Cook","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0091-3057(94)90472-3","article-title":"Ethopharmacological analysis of rat behavior on the elevated plus-maze","volume":"49","author":"Cruz","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib13","first-page":"CD006162","article-title":"Rimonabant for overweight or obesity","volume":"4","author":"Curioni","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF02245961","article-title":"Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity","volume":"118","author":"Dawson","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib15","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despres","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(95)01486-1","article-title":"Neuroanatomical characterization of fos induction in rat behavioral models of anxiety","volume":"713","author":"Duncan","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1527-3458.2007.00025.x","article-title":"Pharmacology of the beta-carboline FG-7, 142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects","volume":"13","author":"Evans","year":"2007","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0031-9384(97)80332-0","article-title":"Devazepide attenuates dl-fenfluramine-induced suppression of gastric emptying but not food intake in the 17 h food-deprived rat","volume":"62","author":"Francis","year":"1997","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2005.11.032","article-title":"Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor \u2018silent antagonist\u2019","volume":"530","author":"Gardner","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib20","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1046\/j.1471-4159.2000.0741363.x","article-title":"Interaction between the serotoninergic and dopaminergic systems in d-fenfluramine-induced activation of c-fos and jun B genes in rat striatal neurons","volume":"74","author":"Gardier","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib21","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1460-9568.2002.02192.x","article-title":"The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety","volume":"16","author":"Haller","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.fbp.0000135704.56422.40","article-title":"CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents","volume":"15","author":"Haller","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(96)00471-2","article-title":"The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze","volume":"312","author":"Hinks","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbr.2008.06.010","article-title":"The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats","volume":"193","author":"Hodge","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","article-title":"A review of the validity and variability of the elevated plus-maze as an animal model of anxiety","volume":"54","author":"Hogg","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0169-328X(92)90219-2","article-title":"Basal expression of fos, fos-related, jun, and krox 24 proteins in rat hippocampus","volume":"13","author":"Hughes","year":"1992","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0091-3057(02)00938-3","article-title":"Interactions between the CB1 receptor agonist delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited","volume":"73","author":"Jarbe","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pbb.2008.06.014","article-title":"Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats","volume":"91","author":"Jarbe","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pbb.2006.08.006","article-title":"Effects of the CB1R agonist WIN-55, 212-2 and the CB1R antagonists SR-141716 and AM-1387: open-field examination in rats","volume":"85","author":"Jarbe","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib31","series-title":"Design and Analysis: a Researcher's Handbook","author":"Keppel","year":"1982"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib32","series-title":"Design and Analysis: a Researcher's Handbook","author":"Keppel","year":"1991"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00213-009-1506-7","article-title":"The future of endocannabinoid-oriented clinical research after CB1 antagonists","volume":"205","author":"Le Foll","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF02245888","article-title":"Anxiogenic drugs beta-CCE and FG 7142 increase extracellular dopamine levels in nucleus accumbens","volume":"109","author":"McCullough","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0091-3057(95)02066-7","article-title":"Aversive effects of the synthetic cannabinoid CP 55, 940 in rats","volume":"53","author":"McGregor","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pbb.2006.02.022","article-title":"Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist\/inverse agonist AM 1387","volume":"83","author":"McLaughlin","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00008877-200312000-00002","article-title":"The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats","volume":"14","author":"McLaughlin","year":"2003","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00213-005-2171-0","article-title":"The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats","volume":"180","author":"McLaughlin","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0031-9384(93)90079-U","article-title":"Sex differences in open-field behavior in response to the beta-carboline FG 7142 in rats","volume":"54","author":"Meng","year":"1993","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0166-2236(89)90096-9","article-title":"Stimulus-transcription coupling in neurons: role of cellular immediate-early genes","volume":"12","author":"Morgan","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.ne.14.030191.002225","article-title":"Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun","volume":"14","author":"Morgan","year":"1991","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib43","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00001756-199701200-00023","article-title":"Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat","volume":"8","author":"Navarro","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib45","series-title":"The Rat Brain in Sterotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib49","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00008877-199711000-00003","article-title":"Animal models of \u2018anxiety\u2019: where next?","volume":"8","author":"Rodgers","year":"1997","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00008877-200509000-00013","article-title":"Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-na\u00efve and plus-maze-experienced mice","volume":"16","author":"Rodgers","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib51","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1126\/science.276.5321.2050","article-title":"Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal","volume":"276","author":"Rodriguez de Fonseca","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-3565(25)12276-3","article-title":"Corticotropin-releasing factor (CRF) antagonist [D-Phe12, Nle21, 38, C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats","volume":"276","author":"Rodriguez de Fonseca","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib53","doi-asserted-by":"crossref","first-page":"R390","DOI":"10.1152\/ajpregu.2000.278.2.R390","article-title":"Dexfenfluramine and norfenfluramine: comparison of mechanism of action in feeding and brain fos-ir studies","volume":"278","author":"Rowland","year":"2000","journal-title":"Am. J. Physiol., Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1098-2396(200001)35:1<8::AID-SYN2>3.0.CO;2-Y","article-title":"In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments","volume":"35","author":"Rubino","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuropharm.2008.04.013","article-title":"Impairment of endocannabinoids activity in the dorsolateral striatum delays extinction of behavior in a procedural memory task in rats","volume":"55","author":"Rueda-Orozco","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00213-001-0994-x","article-title":"Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task","volume":"160","author":"Salamone","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib57","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.physbeh.2007.04.013","article-title":"Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions","volume":"91","author":"Salamone","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib58","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00213-006-0668-9","article-title":"Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits","volume":"191","author":"Salamone","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib59","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.neuropharm.2006.02.008","article-title":"Airjet and FG-7142-induced fos expression differs in rats selectively bred for high and low anxiety-related behavior","volume":"50","author":"Salchner","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib60","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00008877-200312000-00001","article-title":"Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice","volume":"14","author":"Shearman","year":"2003","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0896-6273(90)90106-P","article-title":"The regulation and function of c-fos and other immediate early genes in the nervous system","volume":"4","author":"Sheng","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-3223(02)01574-3","article-title":"Induction of c-fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs","volume":"53","author":"Singewald","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib63","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.npp.1301476","article-title":"The novel cannabinoid CB(1) receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats","volume":"33","author":"Sink","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib64","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00213-007-0988-4","article-title":"Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior","volume":"196","author":"Sink","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pbb.2008.07.013","article-title":"Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113","volume":"91","author":"Sink","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib66","doi-asserted-by":"crossref","first-page":"e2202","DOI":"10.1371\/journal.pone.0002202","article-title":"Feeding induced by cannabinoids is mediated independently of the melanocortin system","volume":"3","author":"Sinnayah","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib67","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/FBP.0b013e3282eff0a9","article-title":"Acute anorectic response to cannabinoid CB1 receptor antagonist\/inverse agonist AM 251 in rats: indirect behavioural mediation","volume":"18","author":"Tallett","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-007-0880-2","article-title":"Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats","volume":"195","author":"Tallett","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(94)91391-9","article-title":"Induction of c-fos in rat brain by acute cocaine and fenfluramine exposure: a comparison study","volume":"647","author":"Torres","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib70","unstructured":"US Food and Drug Administration Advisory Committee. FDA briefing document: zimulti (rimonabant) Tablets, 20mg, FDA, Rockville, 2007. [WWW document]. URL (http:\/\/www.fda.gov\/OHRMS\/DOCKETS\/AC\/07\/briefing\/2007-4306b1-00-index.htm). (accessed September 2008)."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib71","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib72","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00213-002-1384-8","article-title":"Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa\/fa) compared to lean zucker rats","volume":"167","author":"Vickers","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib73","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0196-9781(00)00329-6","article-title":"Does increased endogenous CCK interact with serotonin to reduce food intake in rats?","volume":"21","author":"Voigt","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0149-7634(01)00013-6","article-title":"Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior","volume":"25","author":"Wall","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib75","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bjp.0706157","article-title":"CB1 cannabinoid receptor-mediated modulation of food intake in mice","volume":"145","author":"Wiley","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.11.002_bib76","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050953","article-title":"Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors","volume":"143","author":"Williams","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.11.002_bib77","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0896-6273(90)90118-Y","article-title":"Differential expression of immediate early genes in the hippocampus and spinal cord","volume":"4","author":"Wisden","year":"1990","journal-title":"Neuron"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X09002533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X09002533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T22:05:54Z","timestamp":1739484354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X09002533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0924977X09002533"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2009.11.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}